Initially, we accumulated LJPC between $2.30 and $2.50 in November of 2019. The buying opportunity came after LJPC announced the discontinuation of its research and development program and the … [Read more...] about La Jolla Pharmaceuticals (Nasdaq: LJPC) Investment Update
Footer
We provide an edge in the biotech industry through our consistent data driven insights
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Japanese
Portuguese
Russian
Spanish